InvestorLens

IMVT — IMMUNOVANT INC

Public company

Sign in to save5 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About IMMUNOVANT INC (IMVT)

IMMUNOVANT INC (IMVT) appears in the most recent 13F filings of 5 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $51M. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in IMVT

100
/100
Strong Institutional Accumulation
Added / Increased2
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track IMVT

33
/100
Emerging Interest
5investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

IMVT Ownership Composition

How IMMUNOVANT INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Hedge Funds
82% of tracked value
Institutions
5
tracked investors
Total Reported
$65.1M
combined 13F value
Sectors2
  • Hedge Funds81.7%
  • Other18.3%
Hedge Funds(2)
81.7%
Other(3)
18.3%

Tracked investors reporting IMVT

  • Steve CohenDec 31, 2025
    Point72 Asset Management
    Shares
    2M
    Value
    $50.8M
    % Portfolio
    0.06%
  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    217.3K
    Value
    $5.4M
    % Portfolio
    0.00%
  • Izzy EnglanderDec 31, 2025
    Millennium Management
    Shares
    172.5K
    Value
    $4.4M
    % Portfolio
    0.00%
  • David EinhornMar 31, 2026
    DME Capital Management, LP
    Shares
    93.5K
    Value
    $2.3M
    % Portfolio
    0.07%
  • Paul Tudor JonesDec 31, 2025
    Tudor Investment Corp
    Shares
    84.6K
    Value
    $2.2M
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold IMVT?
5 tracked institutional investors disclosed a position in IMVT (IMMUNOVANT INC) in their most recent 13F filing.
Who is the largest institutional holder of IMVT?
Steve Cohen, Point72 Asset Management, holds the largest disclosed position in IMVT, valued at $51M.
Did institutional ownership of IMVT increase or decrease?
Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 fully exited IMVT.
Where does this IMVT ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.